Here are the Form 4 insider transactions from DENTSPLY SIRONA Inc. (XRAY) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow XRAY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XRAY filings page.
DENTSPLY SIRONA Inc. director Jonathan Jay Mazelsky reported routine equity awards tied to his board service. On January 9, 2026, he acquired 395.158 shares of common stock at $0, representing dividends paid on his existing restricted stock units (RSUs). These dividend RSUs follow the same vesting schedule as the underlying RSUs and each RSU converts into one share of common stock. After this transaction, he beneficially owned 28,846.534 common shares directly.
On the same date, he also acquired 153.7009 phantom stock units under the directors' deferred compensation program at an assigned value of $12.22 per unit, increasing his directly held phantom stock balance to 14,535.2138 units. Each phantom stock unit is economically equivalent to one share of common stock and becomes payable in common stock when his service as a director ends.
DENTSPLY SIRONA Inc. director Gregory T. Lucier reported an automatic award of additional common stock tied to existing restricted stock units. On 01/09/2026, an entity described as a family partnership associated with him received 341.114 shares of common stock at a price of $0, reflecting dividends on his restricted stock units that were paid in the form of additional RSUs.
After this transaction, the family partnership held 24,901.284 common shares indirectly. Separately, an IRA associated with Gregory Lucier held 21,000 common shares indirectly, while his direct common stock holdings were reported as zero. The footnote explains that these dividend RSUs follow the same vesting schedule as the underlying RSU awards and each RSU converts into one share of common stock.
DENTSPLY SIRONA Inc. senior executive Robert Anthony Johnson, SVP and Chief Supply Chain Officer, reported routine equity compensation grants. On January 9, 2026, he acquired 641.625 shares of common stock at a price of $0, representing dividends on existing restricted stock units paid in the form of additional RSUs that vest on the same schedule as the underlying awards. After this, he beneficially owned 116,313.146 shares of common stock directly.
On the same date, he was credited with 40.22 phantom stock units under the Supplemental Executive Retirement Plan at a reference price of $12.22 per unit, bringing his total phantom stock balance to 3,113.1526 units. Each RSU and each phantom stock unit is economically equivalent to one share of common stock, with phantom stock payable in common stock upon his termination of employment.
DENTSPLY SIRONA Inc. director Clyde Hosein reported an automatic stock acquisition tied to his existing equity awards. On 01/09/2026, he received 355.0455 shares of common stock at a price of $0, described as dividends on restricted stock units (RSUs) that are paid in the form of additional RSUs.
The footnote explains that these dividend RSUs carry the same vesting terms as the original RSU awards and will vest at the same time as the underlying grants, with each RSU converting into one share of common stock. Following this transaction, Hosein directly beneficially owned 41,252.522 shares of DENTSPLY SIRONA common stock.
DENTSPLY SIRONA Inc. director Betsy D. Holden reported an automatic share acquisition tied to her existing equity awards. On January 9, 2026, she acquired 710.956 shares of common stock at a price of $0, reflecting dividends on her restricted stock units (RSUs) that were paid in the form of additional RSUs. These dividend RSUs carry the same vesting terms as the underlying awards, and each RSU converts into one share of common stock. Following this transaction, Holden beneficially owned 54,613.852 shares of DENTSPLY SIRONA common stock in direct ownership.
DENTSPLY SIRONA Inc. director Brian T. Gladden reported receiving additional equity-linked compensation. On 01/09/2026, he acquired 314.959 shares of common stock at a price of $0, reported as directly owned. After this transaction, he beneficially owned 29,041.522 shares of DENTSPLY SIRONA common stock.
According to the footnote, these shares represent dividends on existing restricted stock units (RSUs), credited in the form of additional RSUs. These dividend RSUs carry the same vesting terms as the underlying RSU awards, vest simultaneously with them, and each RSU converts into one share of common stock.
DENTSPLY SIRONA Inc. reported that senior vice president and chief human resources officer Andrea L. Frohning acquired additional equity-linked awards on January 9, 2026. She received 392.387 shares of common stock at a price of $0, described as dividends on restricted stock units that are credited as additional RSUs and vest on the same schedule as the underlying awards. After this, she beneficially owned 34,002.252 shares of common stock directly.
Frohning also acquired 22.7283 shares of phantom stock at $12.22 per unit under a Supplemental Executive Retirement Plan, bringing her total phantom stock holdings to 1,759.2738 units. Each phantom stock unit and each RSU is economically equivalent to one share of common stock, with phantom stock payable in common stock upon her termination of employment and RSUs converting into common stock on a 1:1 basis at vesting.
DENTSPLY SIRONA Inc. director Willie A. Deese reported an automatic stock-related transaction. On 01/09/2026, he acquired 201.508 shares of common stock at a price of $0. These shares represent dividends on previously granted restricted stock units (RSUs), paid in the form of additional RSUs that carry the same vesting schedule as the original awards.
Following this transaction, Deese directly beneficially owned 57,748.066 shares of DENTSPLY SIRONA common stock. Each RSU converts into one share of common stock on a 1:1 basis, and the dividend RSUs vest at the same time as the underlying RSUs they relate to.
DENTSPLY SIRONA Inc. VP and Chief Accounting Officer Kevin Czerney reported routine equity-related awards. On January 9, 2026, he acquired 262.7169 shares of common stock at $0, representing dividends paid in the form of additional restricted stock units that follow the same vesting schedule as the underlying RSUs, each converting into one share of common stock.
On the same date, he also acquired 4.0523 shares of phantom stock under the Dentsply Supplemental Savings Plan and 45.13 shares of phantom stock under the Supplemental Executive Retirement Plan at an economic value of $12.22 per phantom share, each economically equivalent to one share of common stock and payable in stock upon termination of employment. Following these transactions, his reported holdings increased to 28,040.786 shares of common stock, 341.201 phantom shares in the savings plan, and 3,493.4336 phantom shares in the retirement plan.
DENTSPLY SIRONA Inc. director Michael J. Barber reported an automatic stock-related transaction. On 01/09/2026, he acquired 245.816 shares of common stock at a price of $0, bringing his directly held beneficial ownership to 17,944.987 shares.
The new shares come from dividends on restricted stock units (RSUs). These dividends were credited in the form of additional RSUs that follow the same vesting schedule as the original RSU awards. Each RSU converts into one share of common stock when it vests, so the reported amount reflects stock tied to his existing equity compensation rather than an open-market purchase.